JPRN-UMIN000003716已完成未知
Medicinal treatment on symptoms in patients with gastroesophageal reflux disease (GERD) refractory to PPIs. Multicenter, randomized, paralleled controlled study - Medicinal treatment for patients with PPIs-refractory GERD patients
Department of Internal Medicine, Saga University Hospital0 个研究点目标入组 120 人开始时间: 2010年6月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients with GERD which had C or D grade esophagitis diagnosed by endoscopic testing. 2) Patients with serious complications (e.g., hepatic, renal, cardiac, pulmonary, hematological, or metabolic diseases) 3) Patients with abscission of upper gastrointestinal tract 4) Patients who had peptic ulcer (excusing cicatrices) or tumor. 5) Patients with disorder in liver, gallbladder, or pancreas 6) Patients with gastrointestinal bleeding, mechanical ileus, gastrointestinal perforation. 7) Patients who received drugs prohibited for concomitant use during the observation period 8) Patients who were received treatment of rabeprazole (20mg) 9) Patients with psychoneurosis 10) Patients with planning or during treatment of investigational drug 11) Patients with pregnant, considering pregnancy or lactation 12) Patients considered inappropriate by the study investigator
研究者
相似试验
已完成
Unknown
Training of primary care practitioners to improve the management of common mental health disordersISRCTN16612927Instituto de Saúde Publica da Universidade do Porto (ISPUP)348
进行中（未招募）
不适用
Treatment response in patients with symptoms due to gastroesophageal reflux disease either with or without esophagitis treated with pantoprazole sodium 40 mg o.d. over 8 weeks - REAL LIFEEUCTR2005-003485-42-DEycomed GmbH2,000
进行中（未招募）
1 期
Treatment response in patients with symptoms due to gastroesophageal reflux disease either with or without esophagitis treated with pantoprazole sodium 40 mg o.d. over 8 weeksRespuesta al tratamiento en pacientes con síntomas debidos a la enfermedad por reflujo gastroesofágico, con o sin esofagitis, tratados con 40 mg de pantoprazol sódico o.d. durante 8 semanas” - REAL LIFEEUCTR2005-003485-42-ESALTANA Pharma AG2,000
进行中（未招募）
不适用
Treatment response in patients with symptoms due to gastroesophageal reflux disease either with or without esophagitis treated with pantoprazole sodium 40 mg o.d. over 8 weeks - REAL LIFEgastroesophageal reflux diseaseMedDRA version: 8.1Level: lltClassification code 10017885EUCTR2005-003485-42-ATALTANA Pharma AG2,000
进行中（未招募）
1 期
Treatment response in patients with symptoms due to gastroesophageal reflux disease either with or without esophagitis treated with pantoprazole sodium 40 mg o.d. over 8 weeks - REAL LIFEgastroesophageal reflux diseaseMedDRA version: 8.1 Level: llt Classification code 10017885EUCTR2005-003485-42-GBycomed GmbH2,000